RxSight, Inc.·4

Jan 19, 4:01 PM ET

Maniar Shweta 4

4 · RxSight, Inc. · Filed Jan 19, 2024

Insider Transaction Report

Form 4
Period: 2024-01-18
Transactions
  • Sale

    Common Stock

    2024-01-18$45.69/sh3,520$160,81215,009 total
  • Sale

    Common Stock

    2024-01-18$45.76/sh2,879$131,74412,130 total
Footnotes (3)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on May 25, 2023 by the Reporting Person.
  • [F2]Represents the weighted average share price of an aggregate total of 3,520 shares sold in the price range of $45.315 to $46.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Represents the weighted average share price of an aggregate total of 2,879 shares sold in the price range of $45.33 to $46.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4